Structures by: Schröder J.
Total: 10
C12H13BrClN3S
C12H13BrClN3S
Journal of Medicinal Chemistry (2001) 44, 20 3231
a=21.3350(6)Å b=9.3150(2)Å c=14.4910(4)Å
α=90.0000(17)° β=102.9950(19)° γ=90.000(3)°
C19H23NO2
C19H23NO2
Tetrahedron (1998) 54, 18 4507-4520
a=9.772(1)Å b=9.876(1)Å c=10.106(1)Å
α=90° β=117.06(1)° γ=90°
C18H19NO3
C18H19NO3
Tetrahedron (1998) 54, 18 4507-4520
a=6.470(1)Å b=13.708(1)Å c=17.352(1)Å
α=90° β=90° γ=90°
C19H21NO3
C19H21NO3
Tetrahedron (1998) 54, 18 4507-4520
a=6.373(1)Å b=14.800(1)Å c=17.892(1)Å
α=90° β=90° γ=90°
C21H25NO2
C21H25NO2
Tetrahedron Letters (1999) 40, 51 9003-9004
a=10.5303(4)Å b=11.7446(8)Å c=14.8819(6)Å
α=90° β=101.617(4)° γ=90°
C21H39B2KN5
C21H39B2KN5
Chemical Communications (2019)
a=24.1981(16)Å b=5.7782(4)Å c=17.2288(11)Å
α=90° β=89.951(4)° γ=90°
(2S)-N-[5-(4-chlorophenyl)-2,3-dihydro-6H-1,3,4-thiadiazin-2-ylidene]-2- (phenylsulfonyl)amino]propanamide
C18H17ClN4O3S2
Acta Crystallographica Section C (2001) 57, 5 593-596
a=15.600(4)Å b=20.764(6)Å c=5.826(3)Å
α=90° β=90° γ=90°
(2R)-N-[5-(4-fluoro-phenyl)-6H-1,3,4-thiadiazin-2-yl]-2- [(phenylsulfonyl)amino]propanamide
C18H17FN4O3S2
Acta Crystallographica Section C (2001) 57, 5 593-596
a=9.675(19)Å b=12.704(19)Å c=15.606(15)Å
α=90° β=90° γ=90°
(2S)-N-[5-(5-chloro-2-thienyl)-6H-1,3,4-thiadiazin-2-yl]-2- [(phenylsulfonyl)amino]propanamide
C16H15ClN4O3S3
Acta Crystallographica Section C (2001) 57, 5 593-596
a=10.613(4)Å b=11.193(4)Å c=16.399(5)Å
α=90° β=102.48(3)° γ=90°
Dichloridobis(1,3-diisopropyl-4,5-dimethyl-1<i>H</i>-imidazol-3-ium-2-thiolate-κ<i>S</i>)copper(II)
C22H40Cl2CuN4S2
Acta Crystallographica Section E (2013) 69, 4 m211
a=14.0663(12)Å b=13.1359(11)Å c=14.9278(13)Å
α=90.00° β=90.00° γ=90.00°